Form 4: STERIS plc Director Christopher Holland Reports Share Acquisition and Disposal
SEC Form 4 Filing
Director Christopher Holland reports acquiring and disposing of STERIS plc shares on August 8, 2024, according to a Form 4 filing.
Summary
- On August 8, 2024, Christopher Holland, a director of STERIS plc, acquired 988 ordinary shares at a price of $239.68 per share.
- On the same day, Mr. Holland disposed of 473 ordinary shares at the same price of $239.68 per share.
- The disposal of shares was to cover taxes required to be withheld pursuant to applicable employment or tax laws.
- Following these transactions, Mr. Holland beneficially owns 582 ordinary shares of STERIS plc.
- Mr. Holland has a power of attorney authorizing Ronald E. Snyder to act on his behalf for SEC filings.
Sentiment
Score: 5
Explanation: The document is a neutral regulatory filing. The transactions themselves don't necessarily indicate positive or negative sentiment, as the disposal was for tax purposes.
Positives
- The acquisition of shares by a director could be seen as a positive signal, indicating confidence in the company's future performance.
Negatives
- The disposal of shares, even for tax purposes, could be interpreted negatively by some investors, although it's a common practice.
Risks
- There are no specific risks mentioned in this document.
- However, any trading activity by insiders is subject to scrutiny and could raise concerns if not properly explained.
Industry Context
This is a routine disclosure of insider trading activity, which is common for publicly traded companies. It provides transparency into the transactions of company insiders.
Comparison to Industry Standards
- Form 4 filings are standard practice for publicly traded companies in the US, ensuring transparency of insider transactions.
- Companies like Medtronic, Johnson & Johnson, and Danaher also have similar insider trading disclosures.
Stakeholder Impact
- The transactions could have a minor impact on shareholders' perception of the company, depending on how they interpret the insider activity.
- The impact on other stakeholders (employees, customers, suppliers, creditors) is likely negligible.
Key Dates
| Date | Description |
|---|---|
| November 5, 2023 | Date of Power of Attorney authorization by Christopher S. Holland. |
| August 8, 2024 | Date of share acquisition and disposal transactions. |
| August 12, 2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.